Clincosm LogoSign in Get a demo

chronic lymphocytic leukemia

Showing NaN - NaN of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Biomarker for Infection Risk in CLL and MM

Not yet recruiting
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Screening
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
May 3, 2023

Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Anemia
  • +2 more
  • Birmingham, Alabama
  • +795 more
Jan 28, 2023

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • Electronic Health Record Review
  • Duarte, California
  • +10 more
Jan 12, 2023

Chronic Lymphocytic Leukemia, Richter Syndrome Trial in United States (Duvelisib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Richter Syndrome
  • Miami, Florida
  • +6 more
Jan 6, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Odronextamab multiple dose levels)

Recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Odronextamab multiple dose levels
  • Orange, California
  • +20 more
Dec 14, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Coral Gables, Florida
  • +8 more
Sep 28, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
Aug 19, 2022

Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Boston, Massachusetts
  • +2 more
Aug 19, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Understanding Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Aug 1, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +9 more
    Jul 8, 2022

    Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Huntsville, Alabama
    • +87 more
    Apr 25, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +2 more
    Mar 9, 2022

    Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +1 more
    Mar 10, 2022

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Tucson, Arizona
    • +9 more
    Feb 10, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +12 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
    • +2 more
    Feb 17, 2022

    Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • La Jolla, California
    • +14 more
    Dec 29, 2021